NM_181882.3:c.1390C>T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_181882.3(PRX):c.1390C>T(p.Arg464*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,614,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_181882.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRX | NM_181882.3 | c.1390C>T | p.Arg464* | stop_gained | Exon 7 of 7 | ENST00000324001.8 | NP_870998.2 | |
PRX | NM_001411127.1 | c.1675C>T | p.Arg559* | stop_gained | Exon 7 of 7 | NP_001398056.1 | ||
PRX | XM_017027047.2 | c.1288C>T | p.Arg430* | stop_gained | Exon 4 of 4 | XP_016882536.1 | ||
PRX | NM_020956.2 | c.*1595C>T | 3_prime_UTR_variant | Exon 6 of 6 | NP_066007.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250720Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135762
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461844Hom.: 0 Cov.: 36 AF XY: 0.00000138 AC XY: 1AN XY: 727222
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74440
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The PRX c.1390C>T; p.Arg464Ter variant (rs574861276) is reported in the literature in three individuals affected with Charcot-Marie-Tooth disease (Dohrn 2017, Vill 2017, Sun 2017). This variant is reported as pathogenic in ClinVar (Variation ID: 580375). At ARUP, this variant was detected in trans with another PRX variant c.1043dupG; p.Glu349fs in two siblings affected with CMT type 4F and Dejerine-Sottas disease. This variant induces an early termination codon and is predicted to result in a truncated protein. Based on available information, this variant is considered to be pathogenic. References: Dohrn et al. Frequent genes in rare diseases: panel-based next generation sequencing to disclose causal mutations in hereditary neuropathies. J Neurochem. 2017 Dec;143(5):507-522. Vill et al. Jumping Mechanography as a Complementary Testing Tool for Motor Function in Children with Hereditary Motor and Sensory Neuropathy. Neuropediatrics. 2017 Dec;48(6):420-425. Sun et al. Clinical and genetic spectra of Charcot-Marie-Tooth disease in Chinese Han patients. J Peripher Nerv Syst. 2017 Mar;22(1):13-18. -
Charcot-Marie-Tooth disease type 4 Pathogenic:1
This sequence change results in a premature translational stop signal in the PRX gene (p.Arg464*). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 998 amino acids of the PRX protein. For these reasons, this variant has been classified as Pathogenic. A different truncation (p.Cys715*) that lies downstream of this variant has been determined to be pathogenic (PMID: 12112076). This suggests that deletion of this region of the PRX protein is causative of disease. This variant has been reported in an individual affected with Charcot-Marie-Tooth disease, type 4F (PMID: 27862672). This variant is present in population databases (rs574861276, ExAC 0.01%). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at